#United States #Pleasanton #Healthcare Triangle #Teyame AI #HCTI

Healthcare Triangle Inc. Announces the Distribution of Teyame AI Holdings Shares

Healthcare Triangle, Inc. (NASDAQ: HCTI), a prominent player in healthcare technology, is making headlines as it plans to distribute a minority stake in Teyame AI Holdings Inc. to its shareholders. This strategic move comes alongside the company's anticipated direct listing on NASDAQ, further expanding its footprint in the healthcare technology space.

The announcement was made on September 3, 2026, detailing the company's strategy to enhance value for its shareholders while facilitating the separation from its subsidiary Teyame AI Holdings. This subsidiary is known for its AI-driven customer engagement services, which HCTI passionately supports through its cloud and digital transformation solutions.

The Separation Agreement

The cornerstone of this development is the formal separation agreement between HCTI and Teyame AI Holdings, which delineates the responsibilities, asset allocations, and liabilities each entity will carry post-separation. HCTI’s Board of Directors has approved this strategic separation as part of its ongoing efforts to streamline operations and foster growth in a rapidly evolving industry.

According to the agreement, HCTI will distribute a portion of its Teyame AI Holdings shares to current HCTI shareholders. The specific number of shares and date of distribution will be determined in future filings once NASDAQ gives its approval for the direct listing. This stock dividend is set to reward HCTI shareholders, allowing them to participate directly in the promising future of Teyame AI Holdings.

About Teyame AI Holdings

Teyame AI Holdings holds significant value for HCTI, as it encompasses the recently acquired AI-centric businesses, namely Teyame 360 S.L. and Datono Mediación S.L. These acquisitions, stemming from a definitive share purchase agreement enacted in January 2026, have positioned HCTI as a leader in providing AI-powered solutions aimed at enhancing customer experiences in the healthcare space.

The upcoming direct listing of Teyame AI Holdings on NASDAQ is of critical importance. It will showcase the combined value of Teyame's innovative offerings and infrastructure to a broader investment community. This step not only holds potential financial benefits for HCTI but also magnifies its technological insights and capabilities, attracting potential investors interested in the intersection of AI and healthcare.

What’s Next for HCTI and Teyame AI?

Completion of the direct listing remains contingent upon review and approval from the U.S. Securities and Exchange Commission (SEC) and other regulatory bodies. Both HCTI and Teyame are optimistic about this next chapter, recognizing that the approval will open pathways for further expansion and innovation.

In a market increasingly driven by data and technology, HCTI stands out as a healthcare technology innovator. By transferring assets to Teyame AI Holdings, HCTI aims to focus its resources on continuing to provide cutting-edge cloud solutions, enhance digital transformation efforts, and facilitate deep AI integrations in healthcare environments.

Shareholders of HCTI can look forward to detailed communications regarding the record date, additional updates about the listing process, and other essential information as this exciting journey unfolds. Although no securities are up for sale at this moment, the anticipation surrounding the stock dividend and direct listing ceratinly creates waves of enthusiasm in the investment community.

Healthcare Triangle Inc.'s initiatives reflect a broader trend where healthcare companies are embracing technology and innovation to drive growth and efficiency. By creating direct avenues for shareholder engagement and investment, HCTI sets itself on an ambitious trajectory that could redefine opportunities in healthcare technology.

As the world increasingly turns to digital solutions for complex challenges, HCTI’s forward-thinking strategy is certain to position it as a transformative force in the healthcare landscape.